The human brain is a complex chemical and electrical network, with specialized receptors that influence our emotions, behavior, and perception. Understanding these chemicals and their locations gives insight into why we feel pleasure, stress, or motivation—and how drugs can dramatically alter these signals.

 

#	Chemical	Receptor	Locations	Discovered	Role
1	Dopamine	D?–D?	Ventral tegmental area (VTA), nucleus accumbens, prefrontal cortex (bilateral)	Arvid Carlsson, 1950s	Motivation, reward, learning, pleasure
2	Serotonin	5?HT?–5?HT?	Raphe nuclei, frontal cortex, amygdala, hippocampus	Maurice M. Rapport, 1948	Mood regulation, sleep, appetite, emotional stability
3	Norepinephrine	α?, α?, β?–β? adrenergic	Locus coeruleus, frontal cortex, amygdala, hippocampus	Ulf von Euler, 1946	Alertness, focus, fight-or-flight response
4	Endorphins	μ, δ, κ opioid	Nucleus accumbens, amygdala, hypothalamus, thalamus, frontal cortex	Candace Pert & Solomon Snyder, 1970s	Pain relief, pleasure, reward
5	Oxytocin	Oxytocin receptor	Hypothalamus, amygdala, nucleus accumbens, prefrontal cortex	Vincent du Vigneaud, 1953	Bonding, trust, social connection

These chemicals are distributed across both hemispheres of the brain, often overlapping in regions that govern emotion, reward, and decision-making. Modern neuroscience shows that happiness and mood are produced by networks, not isolated “centers.”

 

Stress and Arousal Chemicals
 

• Cortisol: Produced in the adrenal glands, affects the amygdala, hippocampus, and frontal cortex; regulates stress responses.
• Adrenaline (epinephrine): From adrenal medulla; targets brain stem and limbic regions, triggering alertness and fight-or-flight reactions.

 

Stress hormones like cortisol and adrenaline push your body into action, while brain regions like the amygdala (emotion), brain stem (survival functions), and lobes (decision-making, memory, perception) shape how you experience the world.

 

When this balance is disrupted—by stress, habits, or substances—your perception of reality and motivation can change fast. For example, dopamine plays a major role in reward. Natural experiences might raise it moderately, but certain drugs can spike it dramatically, creating a gap between real life and artificial highs.

Disclaimer: Altering brain chemistry outside medically approved guidance is not advised. This is for educational purposes only.
There are also structural and medical considerations. Historically, procedures like lobotomies attempted to alter brain function, but modern medicine strongly rejects unsafe or non-evidence-based interventions.

 

WET BRAIN, DRUG USE

Noticeable Symptoms:

• Left/Right Brain Areas (scientific names):
  • Cerebellum: motor coordination deficits
  • Frontal lobe (bilateral): executive dysfunction, decision-making problems
  • Hippocampus: memory impairment
  • Thalamus: sensory processing disruption
  • Corpus callosum: reduced inter-hemispheric communication

Conditions like “wet brain” (linked to severe alcohol misuse) demonstrate how long-term chemical imbalances can damage memory, cognition, and emotional regulation. Meanwhile, substances interacting with cannabinoid receptors, serotonin pathways (e.g., 5?HT / 5?HTP), or other hallucinogenic systems can unpredictably affect mood, perception, and behavior.

 

---

 

Controlled Substance Classification (U.S.)

Schedule I – high abuse potential, no accepted medical use

• LSD
• Psilocybin (magic mushrooms)
• DMT (Iowaska?)
• Mescaline (peyote)
• MDMA (empathogen/hallucinogen)
• Ibogaine

Schedule II – high abuse potential, limited medical use

• PCP (phencyclidine)
• Ketamine (medical formulations, dissociative hallucinogen)

 

Schedule III – moderate/low physical dependence

• Some ketamine formulations (depending on medical context)

Schedule IV – lower abuse risk

• No major classic hallucinogens typically listed here

Schedule V – lowest risk

• No widely recognized hallucinogens in this category

Quick clarity:

• Classic hallucinogens: LSD, psilocybin, mescaline
• Dissociatives: PCP, ketamine
• Deliriants (rare, dangerous): scopolamine

 

---

Cannabis (Marijuana) and Federal Scheduling Timeline

• 1970: Controlled Substances Act enacted (Schedules I–V); marijuana placed in Schedule I (no accepted medical use, high abuse potential)
• 1972: First petition to review Schedule I status
• 1988: DEA judge recommended removal; rejected in 1990
• 1995 / 2001: Petitions filed and denied
• 2002 / 2011: Petitions filed and denied (2011 final denial)
• 2016: Governors’ petition denied
• October 6, 2022: Presidential review directed
• August 29, 2023: HHS recommended rescheduling to Schedule III
• May 2024: Notice of proposed rulemaking issued
• December 18, 2025: Executive order directs fast-track to Schedule III (law still lists Schedule I until DEA finalizes rule)

 

Receptors in the Brain: Emotions, Drugs, and Affected Areas

The human brain is a complex chemical and electrical network, with specialized receptors that influence our emotions, behavior, and perception. Understanding these chemicals and their locations gives insight into why we feel pleasure, stress, or motivation—and how drugs can dramatically alter these signals.

 

---

Happy Chemicals and Their Brain Receptors

#	Chemical	Receptor	Locations	Discovered	Role
1	Dopamine	D?–D?	Ventral tegmental area (VTA), nucleus accumbens, prefrontal cortex (bilateral)	Arvid Carlsson, 1950s	Motivation, reward, learning, pleasure
2	Serotonin	5?HT?–5?HT?	Raphe nuclei, frontal cortex, amygdala, hippocampus	Maurice M. Rapport, 1948	Mood regulation, sleep, appetite, emotional stability
3	Norepinephrine	α?, α?, β?–β? adrenergic	Locus coeruleus, frontal cortex, amygdala, hippocampus	Ulf von Euler, 1946	Alertness, focus, fight-or-flight response
4	Endorphins	μ, δ, κ opioid	Nucleus accumbens, amygdala, hypothalamus, thalamus, frontal cortex	Candace Pert & Solomon Snyder, 1970s	Pain relief, pleasure, reward
5	Oxytocin	Oxytocin receptor	Hypothalamus, amygdala, nucleus accumbens, prefrontal cortex	Vincent du Vigneaud, 1953	Bonding, trust, social connection

These chemicals are distributed across both hemispheres of the brain, often overlapping in regions that govern emotion, reward, and decision-making. Modern neuroscience shows that happiness and mood are produced by networks, not isolated “centers.”

 

---

Stress and Arousal Chemicals

• Cortisol: Produced in the adrenal glands, affects the amygdala, hippocampus, and frontal cortex; regulates stress responses.
• Adrenaline (epinephrine): From adrenal medulla; targets brain stem and limbic regions, triggering alertness and fight-or-flight reactions.

 

---

Key Brain Areas for Emotion vs Senses

• Emotion / Mood: Amygdala, hippocampus, hypothalamus, prefrontal cortex, nucleus accumbens.
• Sensory Processing: Frontal lobe (executive), parietal lobe (touch/proprioception), occipital lobe (vision), temporal lobe (hearing), insula (internal sensing), thalamus (relay hub).
• Note: Emotional and sensory networks overlap; stability and mood regulation arise from coordinated activity.

 

---

Drug Interactions and Warnings

Disclaimer: Altering the brain’s organic chemistry outside approved medical contexts is extremely dangerous. The following is for educational purposes only.

• MDMA (Ecstasy): Schedule I, no accepted medical use federally, high abuse potential.
• Methamphetamine: Schedule II, limited medical use (ADHD, obesity), high abuse potential.
• Ketamine: Schedule III, used medically for anesthesia and depression, moderate/low dependence risk.
• Cannabinoids: Variable legal status; federal cannabis remains Schedule I, though rescheduling efforts continue.

Hallucinogens (Schedule I unless noted): LSD, psilocybin, mescaline, DMT, MDMA. Dissociatives like PCP and ketamine have separate classifications. Always exercise caution and rely on current medical guidance.

 

---

 

 

Δ??THC binds to CB?, which is a G?protein-coupled receptor (GPCR). That means CB? is a protein embedded in the neuron’s cell membrane, not something that gets made anew when THC binds. THC acts as a ligand—it physically fits into the receptor’s binding site like a key in a lock.

When THC binds:

CB? changes shape (conformational change).

This activates the G-protein inside the neuron.

The G-protein triggers a cascade of intracellular signals (like reducing cAMP levels, changing ion channel activity).

The neuron’s activity is modulated—this is what produces effects like altered perception, mood changes, or appetite stimulation.

So THC binds to the receptor, it doesn’t create or synthesize the receptor. CB? is already there, made by the neuron’s normal protein synthesis processes.

If you want, I can make a super-clean blog-ready version explaining Δ??THC vs CB? vs endocannabinoids in one concise paragraph that fits your post. Do you want me to do that.

 

Our brain’s chemical landscape is vast, intricate, and finely balanced. From dopamine’s reward signals to cortisol’s stress responses, understanding receptors, brain regions, and neurotransmitters explains much about human behavior and why drugs can be so impactful.

For educators, researchers, and curious minds, this knowledge underscores the importance of respecting brain chemistry and the power of networked emotional regulation.

 

---

 

Follow our blog for more insights on neuroscience, pharmacology, and human behavior.

 

Socials: Follow on Instagram, Twitter, and YouTube for updates.

 

---